CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 175 enrolled
Drug / intervention
GORE® EXCLUDER® Conformable AAA Endoprosthesisdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02489539
NCT02489539N/AActive
CompareCT.gov

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

W.L.Gore & Associates·interventional·Posted Jul 3, 2015·Updated Aug 13, 2025

In Brief

A clinical study evaluating GORE® EXCLUDER® Conformable AAA Endoprosthesis for Aortic Aneurysm, Abdominal. Active but no longer recruiting, targeting 175 participants across 51 sites.

Detailed Summary

The purpose of the study is to assess the safety and effectiveness of the GORE® EXCLUDER® Conformable AAA Endoprosthesis to treat an infrarenal aneurysm located in the abdominal aorta. Performance of the GORE® EXCLUDER® Conformable AAA Endoprosthesis will be judged by separate performance goals.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAortic Aneurysm, Abdominal
CountriesUnited States
Collaborators--

Timeline

N/AActive
2016201720182019202020212022202320242025202620272028
First PostedJul 3, 2015
Enrollment StartDec 19, 2017
Primary CompletionMay 25, 2023
Study CompletionDec 31, 2027
TodayJul 2, 2026
Enrollment to primary: 5.4 yearsPosted 11.0 years ago

Interventions

GORE® EXCLUDER® Conformable AAA Endoprosthesisdevice

Endovascular Aneurysm repair (EVAR) is a minimally invasive procedure designed to exclude an aneurysmal segment of the aorta from blood circulation. The EVAR procedure involves delivery of a stent- graft compressed onto a catheter to an aneurysmal segment of the aorta from a remote access site, generally the femoral artery. Arterial access may be done by either percutaneous or cut-down technique.